Author:
Wang Mengyan,Cui Yahui,Shi Jinchuan,Yan Jun
Abstract
Abstract
Background
Mycobacterium avium complex (MAC) is an uncommon clinical pathogen, especially in the central nervous system (CNS), and carries a poor prognosis. MAC infections commonly present as immune reconstitution disease (IRD) in HIV patients. Herein, we report a case of intracranial infection caused by MAC in an AIDS patient without disseminated MAC (DMAC) and immune reconstitution inflammatory syndrome (IRIS).
Case presentation
A 31-year-old HIV-positive male presented us with progressively worsening CNS symptoms, and neuroimaging revealed ring-enhancing lesions. The intracranial lesions worsened after the empirical therapy for toxoplasma encephalitis and fungal infection. Due to the rapid progression of the disease, the patient died. Mycobacterium avium was the only pathogen in brain tissue after cultures and molecular biology tests.
Conclusion
MAC infection in CNS is challenging to diagnose in HIV patients. Our findings emphasize that obtaining tissue samples and applying molecular biology methods is essential to help diagnose the patient as soon as possible to receive adequate treatment.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Daley CL. Mycobacterium avium Complex Disease. Microbiol Spectr 2017, 5(2).
2. Meena DS, Kumar D, Meena V, Bohra GK, Tak V, Garg MK. Epidemiology, clinical presentation, and predictors of outcome in nontuberculous mycobacterial central nervous system infection: a systematic review. Trop Med Health. 2023;51(1):54.
3. Flor A, Capdevila JA, Martin N, Gavaldà J, Pahissa A. Nontuberculous mycobacterial meningitis: report of two cases and review. Clin Infect Dis. 1996;23(6):1266–73.
4. Karne SS, Sangle SA, Kiyawat DS, Dharmashale SN, Kadam DB, Bhardwaj RS. Mycobacterium avium-intracellulare brain abscess in HIV-positive patient. Ann Indian Acad Neurol. 2012;15(1):54–5.
5. Health UDo, Services H. Panel on opportunistic infections in adults and adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention. the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. In.;; 2020.